Alex De Winter, PhD
Alex is a Managing Director with GE Ventures, where he focuses on precision medicine. He has led investments in Labcyte, RainDance Technologies, Syapse, and Veracyte.
Alex joined GE from Mohr Davidow Ventures, where he specialized in healthcare and life sciences startups. At Mohr Davidow, he worked with portfolio companies CardioDx, Corventis, Crescendo Bioscience, DVS Sciences, and Personalis.
Previously, Alex was a Senior Scientist at Pacific Biosciences, working on systems integration for its Single Molecule Real Time DNA sequencer. He started his career as a scientist at 454 Life Sciences, where he worked on what became the first of the next-generation DNA sequencers.
Alex has a PhD in Chemistry from Stanford University, an MBA from UC Berkeley, and degrees in English and Chemistry from Amherst College.